Efficacy of Treatment with Angiotensin II Receptor Antagonist Losartan in Patients with Isolated systolic Hypertension and Reduced Left Ventricular Systolic Function Taking Angiotensin-Converting Enzyme Inhibitor Lisinopril

被引：0
|
作者：
Vatinian, Susanna
Gurgenyan, Svetlana
Nikoghosyan, Karine
机构：
来源：
CIRCULATION | 2010年 / 122卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P876
引用
收藏
页码：E267 / E267
页数：1
相关论文
共 50 条
  • [21] Concomitant use of carvedilol to angiotensin converting enzyme inhibitor therapy in patients with left ventricular systolic dysfunction
    Ramesh, Goyal
    Purvi, Gandhi
    Anil, Jain
    Mallya, Srinivas
    Vishal, Gupta
    Dhiren, Shah
    Bharat, Trivedi
    Naman, Shastri
    Chirag, Mehta
    Kalpana, Jain
    Niren, Bhavsar
    Milan, Chag
    Ajay, Naik
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 138 - 138
  • [22] Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: A review of clinical studies of telmisartan and Enalapril
    Smith, DHG
    CLINICAL THERAPEUTICS, 2002, 24 (10) : 1484 - 1501
  • [23] ALL PATIENTS WITH LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION SHOULD BE TREATED WITH AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - A PROTAGONISTS VIEWPOINT
    MASSIE, BM
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (04): : 439 - 443
  • [24] Addition of angiotensin II receptor blockade to angiotensin-converting enzyme inhibition improves baroreflex function in patients with left ventricular dysfunction
    Kawamura, A
    Yuasa, F
    Yuyama, R
    Mimura, J
    Iwasaki, M
    Sugiura, T
    Iwasaka, T
    EUROPEAN HEART JOURNAL, 2002, 23 : 327 - 327
  • [25] Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy
    Nakamura, T
    Ushiyama, C
    Suzuki, S
    Hara, M
    Shimada, N
    Sekizuka, K
    Ebihara, I
    Koide, H
    AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (05) : 373 - 379
  • [26] I/D polymorphism of the angiotensin-converting enzyme gene does not predict isolated systolic or systolic diastolic hypertension in the elderly
    Johnson, AG
    Simons, LA
    Friedlander, Y
    Simons, J
    Davis, DR
    MaCallum, J
    JOURNAL OF HUMAN HYPERTENSION, 1996, 10 (03) : 167 - 169
  • [27] ANGIOTENSIN-CONVERTING ENZYME INHIBITORS/ANGIOTENSIN RECEPTOR BLOCKERS IN ELDERLY PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AND ADVANCED CHRONIC KIDNEY DISEASE: DANGER OR BENEFIT?
    Milla, Juan Martinez
    Cortes, Marcelino
    Monteagudo, Ana Lucia Rivero
    Castillo, Marta Lopez
    Devesa, Ana
    Urquia, Mikel Taibo
    Mariscal, Maria Luisa Martin
    Briongos-Figuero, Sem
    Pelaez, Juan Antonio Franco
    Tunon, Jose
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 805 - 805
  • [28] Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
    MRP Makdisse
    AG Correa
    M Knobel
    S Lagudis
    F Bacal
    SS Morhy
    CH Fischer
    MLC Vieira
    EBL Filho
    PKO Yokota
    E Knobel
    Critical Care, 11 (Suppl 3):
  • [29] Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension
    Sato, A
    Suzuki, Y
    Saruta, T
    HYPERTENSION RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 22 (01): : 17 - 22
  • [30] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
    Zhang, Chao
    Zhong, Jun
    Chen, Wei-Xiang
    Zhang, Xu-Yang
    Li, Yu-Hong
    Zhou, Teng-Yuan
    Zou, Yong-Jie
    Lan, Chuan
    Li, Lan
    Lai, Zhao-Pan
    Feng, Hua
    Hu, Rong
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 355 - 363
12345